I have yet to meet a highly technical person that can effectively promote a good story.
Scientists get bogged down in the detail, their peer reviews, 'the confidentiality' ... so any exciting developments message simply won't get effectively delivered (in a timely fashion) to the brokers, or their investors.
I think the current lack of information about the animal trials starting is a significant oversight, and it needs to be fixed very quickly.
The rest of the promotion side needs to be addressed by RH and the Board very soon, as the current IR strategy has been poor ... or is really non existent.
We don't need Nick Wolfe back though!
I think RH should be totally focussed on running all the science, so the Board needs to identify someone with proven marketing experience to help them get traction with new investors.
A refresh of non executive directors may achieve that .... If they identify the right people.
PYC Price at posting:
1.4¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)